Strategies for assessing and managing the adverse events of sorafenib and other targeted therapies in the treatment of renal cell and hepatocellular carcinoma: recommendations from a European nursing task group.

Josephine Koldenhof

Strategies for assessing and managing the adverse events of sorafenib and other targeted therapies in the treatment of renal cell and hepatocellular carcinoma: recommendations from a European nursing task group.

Josephine Koldenhof

Dept of Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Article number	10.1016/j.ejon.2011.05.001
Journal	European Journal of Oncology Nursing
Volume	2012
Issue number	april
Publication status	Published - Apr 2012

Cite this

@article{5a8ecd10260841b5a7a3480bc94fcadc,

title = "Strategies for assessing and managing the adverse events of sorafenib and other targeted therapies in the treatment of renal cell and hepatocellular carcinoma: recommendations from a European nursing task group.",

author = "Josephine Koldenhof",

year = "2012",

month = apr,

language = "English",

volume = "2012",

journal = "European Journal of Oncology Nursing",

issn = "1462-3889",

publisher = "Churchill Livingstone",

number = "april",

}

Strategies for assessing and managing the adverse events of sorafenib and other targeted therapies in the treatment of renal cell and hepatocellular carcinoma: recommendations from a European nursing task group. / Koldenhof, Josephine.
In: European Journal of Oncology Nursing, Vol. 2012, No. april, 10.1016/j.ejon.2011.05.001, 04.2012.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Strategies for assessing and managing the adverse events of sorafenib and other targeted therapies in the treatment of renal cell and hepatocellular carcinoma: recommendations from a European nursing task group.

AU - Koldenhof, Josephine

PY - 2012/4

Y1 - 2012/4

M3 - Article

SN - 1462-3889

VL - 2012

JO - European Journal of Oncology Nursing

JF - European Journal of Oncology Nursing

IS - april

M1 - 10.1016/j.ejon.2011.05.001

ER -